Evidence map›Paper›PMID 40534692›Full record

ArticleFrontiers in medicine2025

Optimizing diagnostic and management pathways for patients with eosinophilia of unknown origin: a multidisciplinary protocol for urgent and non-urgent evaluation.

Silvia Sánchez-Ramón, Gloria Candelas Rodríguez, Jesús Gimeno Hernández, María Luisa González Gutiérrez, Sissy Fiorella Medina Salazar, Manuel Méndez Bailón, Begoña Navas Elorza, Ángel Nieto Sánchez, Teresa Robledo Echarren, Santiago Rueda Esteban and 6 more

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Silvia Sánchez-RamónDepartment of Clinical Immunology, Hospital Clínico San Carlos, Madrid, Spain.
Gloria Candelas RodríguezDepartment of Rheumatology, Hospital Clínico San Carlos, Madrid, Spain.
Jesús Gimeno HernándezDepartment of ENT, Hospital Clínico San Carlos, Madrid, Spain.
María Luisa González GutiérrezDepartment of Allergy, Hospital Clínico San Carlos, Madrid, Spain.
Sissy Fiorella Medina SalazarDepartment of Hematology and Hemotherapy, Hospital Clínico San Carlos, Madrid, Spain.
Manuel Méndez BailónDepartment of Internal Medicine, Hospital Clínico San Carlos, Madrid, Spain.
Begoña Navas ElorzaDepartment of Hematology and Hemotherapy, Hospital Clínico San Carlos, Madrid, Spain.
Ángel Nieto SánchezDepartment of Internal Medicine, Hospital Clínico San Carlos, Madrid, Spain.
Teresa Robledo EcharrenDepartment of Allergy, Hospital Clínico San Carlos, Madrid, Spain.
Santiago Rueda EstebanDepartment of Pediatrics, Hospital Clínico San Carlos, Madrid, Spain.
Marcos Oliver Fragiel SaavedraDepartment of Internal Medicine (Emergency Room), Hospital Clínico San Carlos, Madrid, Spain.
María Dolores Zamora BarriosDepartment of Pharmacy, Hospital Clínico San Carlos, Madrid, Spain.
Cristina Martínez PradaDepartment of Rheumatology, Hospital Clínico San Carlos, Madrid, Spain.
Celina Benavente CuestaDepartment of Hematology and Hemotherapy, Hospital Clínico San Carlos, Madrid, Spain.
Celia Pinedo SierraDepartment of Pulmonology, Hospital Clínico San Carlos, Madrid, Spain.
EOS Multidisciplinary Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Persistent eosinophilia of unknown cause is a key feature of numerous health disorders. These conditions present diagnostic and management challenges, often leading to delayed treatment, increased morbidity and mortality and unnecessary healthcare costs. A systematic approach to patient flow can streamline the process from presentation with eosinophilia to triage management, in hospital settings. Methods: A proposal of a novel patient flow pathway was developed through a collaborative effort involving 15 diverse multidisciplinary specialists in a public-funded tertiary teaching hospital located in Madrid, Spain, for managing eosinophilic diseases. This pathway focuses on early identification and expedited referral circuits in severe cases of hypereosinophilia and early screening of primary immunodeficient patients to optimize the journey from initial presentation through diagnosis and initial management. Results: The proposed patient flow model is designed to be replicable in other hospital settings. Its implementation aims to facilitate timely diagnosis and reduce the preventable morbidity, mortality, suffering and economic burden associated with complex eosinophilic conditions. Conclusion: The development and implementation of a structured patient flow pathway for eosinophilia of unknown cause in a tertiary hospital setting demonstrates a significant step toward improving patient outcomes. This model serves as a template for other healthcare institutions seeking to enhance the management and care of patients with eosinophilic diseases.

Indexed as

chronic rhinosinusitis with nasal polyposisclinical protocoleosinophiliaeosinophilic asthmaeosinophilic granulomatosis with polyangiitishypereosinophilic syndromepatient flowprimary immunodeficiencies

Identifiers

PMID40534692
PMCPMC12174078

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.